Daiichi Sankyo Co Ltd (DSNKY)
35.40
-0.10
(-0.27%)
USD |
OTCM |
May 20, 16:00
Daiichi Sankyo Cash from Financing (Quarterly): -45.43M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -45.43M |
| December 31, 2023 | -275.85M |
| September 30, 2023 | -297.95M |
| June 30, 2023 | -237.05M |
| March 31, 2023 | -54.89M |
| December 31, 2022 | -222.85M |
| September 30, 2022 | -156.87M |
| June 30, 2022 | -228.89M |
| March 31, 2022 | -41.17M |
| December 31, 2021 | -247.68M |
| September 30, 2021 | -211.78M |
| June 30, 2021 | -267.48M |
| March 31, 2021 | -579.66M |
| December 31, 2020 | -677.16M |
| September 30, 2020 | -410.48M |
| June 30, 2020 | -242.30M |
| March 31, 2020 | -24.41M |
| December 31, 2019 | -223.18M |
| September 30, 2019 | -37.81M |
| June 30, 2019 | -557.73M |
| March 31, 2019 | -10.84M |
| December 31, 2018 | -198.56M |
| September 30, 2018 | -176.40M |
| June 30, 2018 | -211.35M |
| March 31, 2018 | -288.30M |
| Date | Value |
|---|---|
| December 31, 2017 | -417.02M |
| September 30, 2017 | -2.638M |
| June 30, 2017 | -210.53M |
| March 31, 2017 | -2.182M |
| December 31, 2016 | -465.44M |
| September 30, 2016 | 650.17M |
| June 30, 2016 | -321.46M |
| March 31, 2016 | -38.39M |
| December 31, 2015 | -396.47M |
| September 30, 2015 | -150.97M |
| June 30, 2015 | -438.59M |
| March 31, 2015 | -54.61M |
| December 31, 2014 | -269.57M |
| September 30, 2014 | -64.27M |
| June 30, 2014 | -820.46M |
| March 31, 2014 | 169.97M |
| December 31, 2013 | -277.73M |
| September 30, 2013 | 1.389B |
| June 30, 2013 | -279.11M |
| March 31, 2011 | 14.70M |
| December 31, 2010 | -190.40M |
| September 30, 2010 | -3.098M |
| June 30, 2010 | -122.93M |
| March 31, 2010 | 32.99M |
| December 31, 2009 | -543.85M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-677.16M
Minimum
Dec 2020
-24.41M
Maximum
Mar 2020
-252.03M
Average
-232.97M
Median
Cash from Financing (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | -450.06M |
| Nxera Pharma Co Ltd | -12.29M |
| PeptiDream Inc | -5.103M |
| Healios KK | 14.90M |
| AnGes Inc | -- |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 297.19M |
| Cash from Investing (Quarterly) | -473.86M |
| Free Cash Flow | 3.302B |
| Free Cash Flow Per Share (Quarterly) | -0.0224 |
| Free Cash Flow to Equity (Quarterly) | 94.99M |
| Free Cash Flow to Firm (Quarterly) | -42.98M |
| Free Cash Flow Yield | 4.86% |